Regulators of prostate cancer stem cells

Candace L. Kerr, Arif Hussain

Research output: Contribution to journalArticle

Abstract

PURPOSE OF REVIEW: Significant advances have been made toward identifying prostate cancer stem cells (CSCs). This review will highlight the latest developments in defining this population and the discovery of mechanisms involved in their survival and metastasis. RECENT FINDINGS: Several groups have identified master regulators of stem cells in prostate cancer. These include genetic and epigenetic factors known to control pluripotency in embryonic stem cells and in highly metastatic prostate tumors. For instance, tumors of patients with poor prognosis demonstrate elevated levels of the pluripotent markers OCT4 and SOX2 as well as the polycomb complex protein Bmi-1 and enhancer of zeste homolog 2. Cells that are derived from these patient tumors provide an opportunity to expand our current knowledge regarding how these cells survive and the mechanisms that regulate their proliferation. SUMMARY: Understanding the mechanisms of highly invasive and therapy resistant prostate cancer cells resides in understanding the CSCs, which facilitate cancer recurrence. Some of these factors are just emerging and provide a platform for developing targeted drugs for the future treatment of advanced prostate cancer.

Original languageEnglish (US)
Pages (from-to)328-333
Number of pages6
JournalCurrent Opinion in Oncology
Volume26
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Neoplastic Stem Cells
Prostatic Neoplasms
Neoplasms
Embryonic Stem Cells
Epigenomics
Prostate
Stem Cells
Neoplasm Metastasis
Recurrence
Survival
Therapeutics
Pharmaceutical Preparations
Population
Proteins

Keywords

  • cancer stem cells
  • metastasis
  • proliferation
  • prostate cancer
  • tumorigenicity

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Regulators of prostate cancer stem cells. / Kerr, Candace L.; Hussain, Arif.

In: Current Opinion in Oncology, Vol. 26, No. 3, 2014, p. 328-333.

Research output: Contribution to journalArticle

Kerr, Candace L. ; Hussain, Arif. / Regulators of prostate cancer stem cells. In: Current Opinion in Oncology. 2014 ; Vol. 26, No. 3. pp. 328-333.
@article{f48adf34d1a64f6ca2671977bc967ba5,
title = "Regulators of prostate cancer stem cells",
abstract = "PURPOSE OF REVIEW: Significant advances have been made toward identifying prostate cancer stem cells (CSCs). This review will highlight the latest developments in defining this population and the discovery of mechanisms involved in their survival and metastasis. RECENT FINDINGS: Several groups have identified master regulators of stem cells in prostate cancer. These include genetic and epigenetic factors known to control pluripotency in embryonic stem cells and in highly metastatic prostate tumors. For instance, tumors of patients with poor prognosis demonstrate elevated levels of the pluripotent markers OCT4 and SOX2 as well as the polycomb complex protein Bmi-1 and enhancer of zeste homolog 2. Cells that are derived from these patient tumors provide an opportunity to expand our current knowledge regarding how these cells survive and the mechanisms that regulate their proliferation. SUMMARY: Understanding the mechanisms of highly invasive and therapy resistant prostate cancer cells resides in understanding the CSCs, which facilitate cancer recurrence. Some of these factors are just emerging and provide a platform for developing targeted drugs for the future treatment of advanced prostate cancer.",
keywords = "cancer stem cells, metastasis, proliferation, prostate cancer, tumorigenicity",
author = "Kerr, {Candace L.} and Arif Hussain",
year = "2014",
doi = "10.1097/CCO.0000000000000080",
language = "English (US)",
volume = "26",
pages = "328--333",
journal = "Current Opinion in Oncology",
issn = "1040-8746",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Regulators of prostate cancer stem cells

AU - Kerr, Candace L.

AU - Hussain, Arif

PY - 2014

Y1 - 2014

N2 - PURPOSE OF REVIEW: Significant advances have been made toward identifying prostate cancer stem cells (CSCs). This review will highlight the latest developments in defining this population and the discovery of mechanisms involved in their survival and metastasis. RECENT FINDINGS: Several groups have identified master regulators of stem cells in prostate cancer. These include genetic and epigenetic factors known to control pluripotency in embryonic stem cells and in highly metastatic prostate tumors. For instance, tumors of patients with poor prognosis demonstrate elevated levels of the pluripotent markers OCT4 and SOX2 as well as the polycomb complex protein Bmi-1 and enhancer of zeste homolog 2. Cells that are derived from these patient tumors provide an opportunity to expand our current knowledge regarding how these cells survive and the mechanisms that regulate their proliferation. SUMMARY: Understanding the mechanisms of highly invasive and therapy resistant prostate cancer cells resides in understanding the CSCs, which facilitate cancer recurrence. Some of these factors are just emerging and provide a platform for developing targeted drugs for the future treatment of advanced prostate cancer.

AB - PURPOSE OF REVIEW: Significant advances have been made toward identifying prostate cancer stem cells (CSCs). This review will highlight the latest developments in defining this population and the discovery of mechanisms involved in their survival and metastasis. RECENT FINDINGS: Several groups have identified master regulators of stem cells in prostate cancer. These include genetic and epigenetic factors known to control pluripotency in embryonic stem cells and in highly metastatic prostate tumors. For instance, tumors of patients with poor prognosis demonstrate elevated levels of the pluripotent markers OCT4 and SOX2 as well as the polycomb complex protein Bmi-1 and enhancer of zeste homolog 2. Cells that are derived from these patient tumors provide an opportunity to expand our current knowledge regarding how these cells survive and the mechanisms that regulate their proliferation. SUMMARY: Understanding the mechanisms of highly invasive and therapy resistant prostate cancer cells resides in understanding the CSCs, which facilitate cancer recurrence. Some of these factors are just emerging and provide a platform for developing targeted drugs for the future treatment of advanced prostate cancer.

KW - cancer stem cells

KW - metastasis

KW - proliferation

KW - prostate cancer

KW - tumorigenicity

UR - http://www.scopus.com/inward/record.url?scp=84899489503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899489503&partnerID=8YFLogxK

U2 - 10.1097/CCO.0000000000000080

DO - 10.1097/CCO.0000000000000080

M3 - Article

VL - 26

SP - 328

EP - 333

JO - Current Opinion in Oncology

JF - Current Opinion in Oncology

SN - 1040-8746

IS - 3

ER -